Janardan Khandekar to Neoplasm Staging
This is a "connection" page, showing publications Janardan Khandekar has written about Neoplasm Staging.
Connection Strength
0.060
-
Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590). Cancer. 2017 Dec 01; 123(23):4653-4662.
Score: 0.024
-
Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. J Natl Cancer Inst. 2007 Oct 17; 99(20):1534-43.
Score: 0.012
-
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA. 2003 Jun 25; 289(24):3243-53.
Score: 0.009
-
The spectrum of vascular lesions in the mammary skin, including angiosarcoma, after breast conservation treatment for breast cancer. J Am Coll Surg. 2001 Jul; 193(1):22-8.
Score: 0.008
-
A phase II study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tract. Cancer. 1989 Dec 15; 64(12):2445-7.
Score: 0.003
-
Treatment of breast carcinoma recurrent after adjuvant chemoimmunotherapy. J Surg Oncol. 1984 Aug; 26(4):233-7.
Score: 0.002
-
Adjuvant chemotherapy for stage II and III breast carcinoma. JAMA. 1980 Jul 18; 244(3):243-6.
Score: 0.002